Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Event is closed!

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Jun 13, 2023 10:02am

29 Views

Post# 35493428

RE:Event is closed!

It is not on for me - are others seeing it???

scarlet1967 wrote: I get this message jistt less than half an hour before the call?! So how can people ask their questions if they didn't earlier? I emailed the IR hopefully no issues during the event.

<< Previous

Bullboard Posts

Next >>

Odd Burger to add 40 locations in Florida